Literature DB >> 34110909

Inflammation, Infection and Venous Thromboembolism.

Meaghan E Colling1,2, Benjamin E Tourdot3, Yogendra Kanthi4.   

Abstract

The association between inflammation, infection, and venous thrombosis has long been recognized; yet, only in the last decades have we begun to understand the mechanisms through which the immune and coagulation systems interact and reciprocally regulate one another. These interconnected networks mount an effective response to injury and pathogen invasion, but if unregulated can result in pathological thrombosis and organ damage. Neutrophils, monocytes, and platelets interact with each other and the endothelium in host defense and also play critical roles in the formation of venous thromboembolism. This knowledge has advanced our understanding of both human physiology and pathophysiology, as well as identified mechanisms of anticoagulant resistance and novel therapeutic targets for the prevention and treatment of thrombosis. In this review, we discuss the contributions of inflammation and infection to venous thromboembolism.

Entities:  

Keywords:  blood platelets; endothelium; infections; inflammasome; inflammation; neutrophils; venous thromboembolism

Mesh:

Year:  2021        PMID: 34110909      PMCID: PMC8202069          DOI: 10.1161/CIRCRESAHA.121.318225

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   23.213


  224 in total

Review 1.  Emerging roles for platelets as immune and inflammatory cells.

Authors:  Craig N Morrell; Angela A Aggrey; Lesley M Chapman; Kristina L Modjeski
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

2.  Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.

Authors:  Joke Konings; José W P Govers-Riemslag; Helen Philippou; Nicola J Mutch; Julian I Borissoff; Peter Allan; Sumitra Mohan; Guido Tans; Hugo Ten Cate; Robert A S Ariëns
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

3.  Platelets Endocytose Viral Particles and Are Activated via TLR (Toll-Like Receptor) Signaling.

Authors:  Meenakshi Banerjee; Yunjie Huang; Smita Joshi; Gabriel J Popa; Michael D Mendenhall; Qing Jun Wang; Beth A Garvy; Thein Myint; Sidney W Whiteheart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-21       Impact factor: 8.311

4.  E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model.

Authors:  Dorian L Culmer; Misha L Dunbar; Angela E Hawley; Suman Sood; Robert E Sigler; Peter K Henke; Thomas W Wakefield; John L Magnani; Daniel D Myers
Journal:  Thromb Haemost       Date:  2017-03-16       Impact factor: 5.249

5.  Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense.

Authors:  Joni M Prasad; Oleg V Gorkun; Harini Raghu; Sherry Thornton; Eric S Mullins; Joseph S Palumbo; Ya-Ping Ko; Magnus Höök; Tovo David; Shaun R Coughlin; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

6.  Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis.

Authors:  John D Welsh; Mark H Hoofnagle; Sharika Bamezai; Michael Oxendine; Lillian Lim; Joshua D Hall; Jisheng Yang; Susan Schultz; James Douglas Engel; Tsutomu Kume; Guillermo Oliver; Juan M Jimenez; Mark L Kahn
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

7.  Differences in signaling pathways by IL-1beta and IL-18.

Authors:  Jae-Kwon Lee; Soo-Hyun Kim; Eli C Lewis; Tania Azam; Leonid L Reznikov; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

8.  Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism.

Authors:  Hannah Fassel; Huigen Chen; Mary Ruisi; Neha Kumar; Maria DeSancho; Katherine A Hajjar
Journal:  Blood       Date:  2021-04-22       Impact factor: 25.476

Review 9.  The interplay between neutrophils, complement, and microthrombi in COVID-19.

Authors:  Yu Zuo; Yogendra Kanthi; Jason S Knight; Alfred H J Kim
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-01-13       Impact factor: 4.098

10.  Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report.

Authors:  Axel Rosell; Sebastian Havervall; Nigel Mackman; Charlotte Thålin; Fien von Meijenfeldt; Yohei Hisada; Katherina Aguilera; Steven P Grover; Ton Lisman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

View more
  25 in total

1.  Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation.

Authors:  Marijke J E Kuijpers; Johan W M Heemskerk; Kerstin Jurk
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

2.  Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study.

Authors:  Federico Angriman; Laura C Rosella; Patrick R Lawler; Dennis T Ko; Hannah Wunsch; Damon C Scales
Journal:  Intensive Care Med       Date:  2022-02-10       Impact factor: 41.787

Review 3.  Targeting the NLRP3 inflammasome in cardiovascular diseases.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Leo F Buckley; Nicola Potere; Marcello Di Nisio; Giuseppe Biondi-Zoccai; Benjamin W Van Tassell; Antonio Abbate
Journal:  Pharmacol Ther       Date:  2021-12-11       Impact factor: 13.400

4.  Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19.

Authors:  Anamika Gupta; Abaher O Al-Tamimi; Rabih Halwani; Hend Alsaidi; Meganathan Kannan; Firdos Ahmad
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-23

5.  Peripheral Vascular Disease in 2021.

Authors:  Nicholas J Leeper; Naomi M Hamburg
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

6.  Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients.

Authors:  Vladimir Otasevic; Biljana Mihaljevic; Natasa Milic; Dejana Stanisavljevic; Vojin Vukovic; Kristina Tomic; Jawed Fareed; Darko Antic
Journal:  Thromb J       Date:  2022-04-19

7.  Endothelial Cell-Activating Antibodies in COVID-19.

Authors:  Hui Shi; Yu Zuo; Sherwin Navaz; Alyssa Harbaugh; Claire K Hoy; Alex A Gandhi; Gautam Sule; Srilakshmi Yalavarthi; Kelsey Gockman; Jacqueline A Madison; Jintao Wang; Melanie Zuo; Yue Shi; Michael D Maile; Jason S Knight; Yogendra Kanthi
Journal:  Arthritis Rheumatol       Date:  2022-05-27       Impact factor: 15.483

8.  Nonspecific ST-Segment and T-Wave (NS-STT) on Electrocardiogram is Associated with Increasing the Incidence of Perioperative Deep Vein Thrombosis in Patients with Lower Extremity Fracture Under 75 Years Old.

Authors:  Cheng Ren; Ming Li; Teng Ma; Yi-Bo Xu; Zhong Li; Han-Zhong Xue; Qian Wang; Yao Lu; Liang Sun; Kun Zhang
Journal:  Int J Gen Med       Date:  2021-11-23

9.  Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.

Authors:  Alessandra Carobbio; Alessandro Maria Vannucchi; Valerio De Stefano; Arianna Masciulli; Paola Guglielmelli; Giuseppe Gaetano Loscocco; Francesco Ramundo; Elena Rossi; Yogendra Kanthi; Ayalew Tefferi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2022-02-10       Impact factor: 11.037

Review 10.  Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome.

Authors:  Jason S Knight; Yogendra Kanthi
Journal:  Semin Immunopathol       Date:  2022-02-04       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.